Terms: = Liver cancer AND NBN, AT-V2, 4683, ENSG00000104320, ATV, FLJ10155, NBS, AT-V1, MGC87362, NBS1
54 results:
1. Development of nanobodies targeting hepatocellular carcinoma and application of nanobody-based CAR-T technology.
Lin K; Xia B; Wang X; He X; Zhou M; Lin Y; Qiao Y; Li R; Chen Q; Li Y; Feng J; Chen T; Chen C; Li X; Zhang H; Lu L; Liu B; Zhang X
J Transl Med; 2024 Apr; 22(1):349. PubMed ID: 38610029
[TBL] [Abstract] [Full Text] [Related]
2. Primary Hepatic Neuroblastoma in a 5.5-Month-Old Boy: A Case Report.
Kompani F; Safari Sharari A; Haji Esmaeil Memar E; Ghahremanloo M
Arch Iran Med; 2024 Jan; 27(1):44-47. PubMed ID: 38431960
[TBL] [Abstract] [Full Text] [Related]
3. Efficient ultrasound-mediated drug delivery to orthotopic liver tumors - Direct comparison of doxorubicin-loaded nanobubbles and microbubbles.
Nittayacharn P; Abenojar E; Cooley MB; Berg FM; Counil C; Sojahrood AJ; Khan MS; Yang C; Berndl E; Golczak M; Kolios MC; Exner AA
J Control Release; 2024 Mar; 367():135-147. PubMed ID: 38237687
[TBL] [Abstract] [Full Text] [Related]
4. Sonosensitizer Nanoplatforms Augmented Sonodynamic Therapy-Sensitizing Shikonin-Induced Necroptosis Against Hepatocellular Carcinoma.
Tian H; Shang H; Chen Y; Wu B; Wang C; Wang X; Cheng W
Int J Nanomedicine; 2023; 18():7079-7092. PubMed ID: 38050474
[TBL] [Abstract] [Full Text] [Related]
5. IR-820@nbs Combined with MG-132 Enhances the Anti-Hepatocellular Carcinoma Effect of Sonodynamic Therapy.
Wang X; Wang C; Tian H; Chen Y; Wu B; Cheng W
Int J Nanomedicine; 2023; 18():6199-6212. PubMed ID: 37933299
[TBL] [Abstract] [Full Text] [Related]
6. Sono-Immunotherapy Mediated Controllable Composite Nano Fluorescent Probes Reprogram the Immune Microenvironment of Hepatocellular Carcinoma.
Chen Y; Wu B; Shang H; Sun Y; Tian H; Yang H; Wang C; Wang X; Cheng W
Int J Nanomedicine; 2023; 18():6059-6073. PubMed ID: 37908671
[TBL] [Abstract] [Full Text] [Related]
7.
Ma XK; Liu TL; Ren YN; Ma XP; Yao Y; Hou XG; Ding J; Wang F; Huang HF; Zhu H; Yang Z
Acta Pharmacol Sin; 2024 Feb; 45(2):436-448. PubMed ID: 37749238
[TBL] [Abstract] [Full Text] [Related]
8. Plasma Circulating Cell-free DNA in Advanced Hepatocellular Carcinoma Patients Treated With Radiation Therapy.
Kim DY; Cho EH; Kim JS; Chie EK; Kang HC
In Vivo; 2023; 37(5):2306-2313. PubMed ID: 37652507
[TBL] [Abstract] [Full Text] [Related]
9. Laparoscopic Anatomical liver Resection of Segment VIII by Using ICG Fluorescence Positive Staining Under the Guidance of Laparoscopic Ultrasonography.
Sun J; Lu ZY; Zhai JX; Lang MR; Wang HG
Ann Surg Oncol; 2023 Nov; 30(12):7358-7359. PubMed ID: 37556011
[TBL] [Abstract] [Full Text] [Related]
10. Investigating the prevalence of pathogenic variants in Saudi Arabian patients with familial cancer using a multigene next generation sequencing panel.
AlHarbi M; Mobark NA; AlJabarat WAR; ElBardis H; AlSolme E; Hamdan AB; AlFakeeh AH; AlMushawah F; AlHarthi F; AlSharm AA; Balbaid AAO; AlJohani N; Zhou AY; Robinson HA; Alqahtani SA; Abedalthagafi M
Oncotarget; 2023 Jun; 14():580-594. PubMed ID: 37306523
[TBL] [Abstract] [Full Text] [Related]
11. Causes of death among patients with hepatocellular carcinoma in United States from 2000 to 2018.
Yang Z; Leng K; Shi G
Cancer Med; 2023 Jun; 12(12):13076-13085. PubMed ID: 37083308
[TBL] [Abstract] [Full Text] [Related]
12. Size-advantage of monovalent nanobodies against the macrophage mannose receptor for deep tumor penetration and tumor-associated macrophage targeting.
Erreni M; D'Autilia F; Avigni R; Bolli E; Arnouk SM; Movahedi K; Debie P; Anselmo A; Parente R; Vincke C; van Leeuwen FWB; Allavena P; Garlanda C; Mantovani A; Doni A; Hernot S; Van Ginderachter JA
Theranostics; 2023; 13(1):355-373. PubMed ID: 36593955
[No Abstract] [Full Text] [Related]
13. Molecular profile and its clinical impact of IDH1 mutated versus IDH1 wild type intrahepatic cholangiocarcinoma.
Rimini M; Fabregat-Franco C; Burgio V; Lonardi S; Niger M; Scartozzi M; Rapposelli IG; Aprile G; Ratti F; Pedica F; Verdaguer H; Rizzato M; Nichetti F; Lai E; Cappetta A; Macarulla T; Fassan M; De Braud F; Pretta A; Simionato F; De Cobelli F; Aldrighetti L; Fornaro L; Cascinu S; Casadei-Gardini A
Sci Rep; 2022 Nov; 12(1):18775. PubMed ID: 36335135
[TBL] [Abstract] [Full Text] [Related]
14. Chrysin reduces hypercholesterolemia-mediated atherosclerosis through modulating oxidative stress, microflora, and apoptosis in experimental rats.
Yuvaraj S; Sasikumar S; Puhari SSM; Ramprasath T; Baskaran N; Vasudevan V; Selvam GS
J Food Biochem; 2022 Nov; 46(11):e14349. PubMed ID: 35892244
[TBL] [Abstract] [Full Text] [Related]
15. RNA-Seq Explores the Mechanism of Oxygen-Boosted Sonodynamic Therapy Based on All-in-One Nanobubbles to Enhance Ferroptosis for the Treatment of HCC.
Chen Y; Shang H; Wang C; Zeng J; Zhang S; Wu B; Cheng W
Int J Nanomedicine; 2022; 17():105-123. PubMed ID: 35027829
[TBL] [Abstract] [Full Text] [Related]
16. Laparoscopic Segmentectomy IV Using Hepatic Round Ligament Approach Combined with Fluorescent Negative Staining Method.
Zheng K; He D; Liao A; Wu H; Yang J; Jiang L
Ann Surg Oncol; 2022 May; 29(5):2980-2981. PubMed ID: 34994890
[TBL] [Abstract] [Full Text] [Related]
17. Nanobubbles Containing sPD-1 and Ce6 Mediate Combination Immunotherapy and Suppress Hepatocellular Carcinoma in Mice.
Tan Y; Yang S; Ma Y; Li J; Xie Q; Liu C; Zhao Y
Int J Nanomedicine; 2021; 16():3241-3254. PubMed ID: 34007176
[TBL] [Abstract] [Full Text] [Related]
18. Oxygen-sufficient lipid nanobubbles combined with UTMD for enhanced sonodynamic therapy of Hep-G2 cells.
Tan H; Tian Y; Yang H; Liu Z; Liang X; Li B; Cheng W
J Biomed Mater Res B Appl Biomater; 2021 Nov; 109(11):1796-1806. PubMed ID: 33838006
[TBL] [Abstract] [Full Text] [Related]
19. Synergistic Anticancer Strategy of Sonodynamic Therapy Combined with PI-103 Against Hepatocellular Carcinoma.
Yang H; Jing H; Han X; Tan H; Cheng W
Drug Des Devel Ther; 2021; 15():531-542. PubMed ID: 33603343
[TBL] [Abstract] [Full Text] [Related]
20. Identification of nanobodies against hepatocellular carcinoma marker glypican-3.
Wang W; Xu C; Wang H; Jiang C
Mol Immunol; 2021 Mar; 131():13-22. PubMed ID: 33453658
[TBL] [Abstract] [Full Text] [Related]
[Next]
